Clinical Trial Update: A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its Safety [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ASP8477 for relief of peripheral neuropathic pain and safety in post-herpetic neuralgia and painful diabetic peripheral neuropathy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain
• Painful Diabetic Peripheral Neuropathy
• Postherpetic Neuralgia

Drugs mentioned

• ASP8477

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Post-Herpetic Neuralgia (PHN), Neuropathic Pain | Phase 2 | Status: COMPLETED